According to Pharma Mar's latest financial reports the company's current EPS (TTM) is $1.64. In 2022 the company made an earnings per share (EPS) of $4.00 a decrease over its 2021 EPS that were of $8.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.66 | -58.55% |
2022 | $4.00 | -50.83% |
2021 | $8.13 | -29.18% |
2020 | $11.48 | -1305.68% |
2019 | -$0.95 | 100.1% |
2018 | -$0.48 | -79.56% |
2017 | -$2.33 | 18.29% |
2016 | -$1.97 | -465.4% |
2015 | $0.54 | -61.21% |
2014 | $1.39 | 31.42% |
2013 | $1.06 | 237.37% |
2012 | $0.31 | -457.73% |
2011 | -$0.08755 | -87.92% |
2010 | -$0.72 | -74.15% |
2009 | -$2.80 | -38.14% |
2008 | -$4.53 |